tiprankstipranks
Aptevo Therapeutics Inc (DE:AP8N)
FRANKFURT:AP8N

Aptevo Therapeutics (AP8N) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Aptevo Therapeutics Inc’s (AP8N) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Aptevo Therapeutics Inc is a Sell.
Aptevo Therapeutics Inc’s (AP8N) 20-Day exponential moving average is 0.12, making it a Sell.
Aptevo Therapeutics Inc’s (AP8N) 50-Day exponential moving average is 0.14, making it a Sell.

Aptevo Therapeutics (AP8N) Pivot Points

Apr 27, 2024, 08:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.11
0.11
0.12
0.13
0.13
0.14
0.14
Fibonacci
0.11
0.12
0.12
0.13
0.13
0.13
0.14
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aptevo Therapeutics (AP8N) Moving Averages

Apr 27, 2024, 08:22 AM
Period
Simple
Exponential
MA5
0.13Sell
0.12Sell
MA10
0.12Sell
0.12Sell
MA20
0.12Sell
0.12Sell
MA50
0.13Sell
0.14Sell
MA100
0.17Sell
0.23Sell
MA200
0.49Sell
0.58Sell
Aptevo Therapeutics Inc’s (AP8N) 10-Day exponential moving average is 0.12, making it a Sell.
Aptevo Therapeutics Inc’s (AP8N) 100-Day exponential moving average is 0.23, making it a Sell.
Aptevo Therapeutics Inc’s (AP8N) 50-day simple moving average is 0.13, creating a Sell signal.
Aptevo Therapeutics Inc’s (AP8N) 100-day simple moving average is 0.17, creating a Sell signal.
Aptevo Therapeutics Inc’s (AP8N) 200-day simple moving average is 0.49, creating a Sell signal.

Aptevo Therapeutics (AP8N) Technical Indicators

Apr 27, 2024, 08:22 AM
Name
Value
Implied Action
RSI (14)
43.99
Neutral
STOCH (9,6)
53.54
Neutral
STOCHRSI (14)
53.54
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
10.62
Buy
Williams %R
-81.82
Buy
CCI (14)
-99.86
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
49.15
Neutral
ROC
-9.45
Sell
Aptevo Therapeutics Inc’s (AP8N) Relative Strength Index (RSI) is 43.99, creating a Neutral signal.
Aptevo Therapeutics Inc’s (AP8N) Trend Strength Indicator (ADX) is 10.62, creating a Buy signal.
Aptevo Therapeutics Inc’s (AP8N) Commodity Channel Index (CCI) is -99.86, creating a Neutral signal.
Aptevo Therapeutics Inc’s (AP8N) Price Rate of Change (ROC) is -9.45, creating a Sell signal.

FAQ

Is AP8N a Buy, Hold, or Sell?
Based on AP8N’s technical indicators, AP8N is a Strong Sell.
    What is AP8N’s RSI (14)?
    AP8N’s RSI (14) is 43.99, which suggests AP8N is a Neutral.
      What is AP8N’s MACD?
      AP8N’s MACD is >-0.01, which suggests AP8N is a Sell.
        What is AP8N’s 5-day moving average?
        AP8N’s 5-day moving average is 0.13, which suggests AP8N is a Sell.
          What is AP8N’s 20-day moving average?
          AP8N 20-day moving average is 0.12, which suggests AP8N is a Sell.
            What is AP8N’s 50-day moving average?
            AP8N’s 50-day moving average is 0.13, which suggests AP8N is a Sell.
              What is AP8N’s 200-day moving average?
              AP8N’s 200-day moving average is 0.49, which suggests AP8N is a Sell.
                What is AP8N’s Williams % R (14)?
                AP8N’s Williams % R (14) is -81.82, which suggests AP8N is a Buy.
                  What is AP8N’s CCI (14)?
                  AP8N’s CCI (14) is -99.86, which suggests AP8N is a Neutral.
                    What is the share price of Aptevo Therapeutics Inc?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis